Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinibDaniel W. Sherbenou, Michael W. Deininger, Adil Humayun et al.|Leukemia|2007Cited by 77
In Chronic Myeloid Leukemia (CML) Patients with Complete Cytogenetic Response to Imatinib, BCR-ABL Kinase Domain Mutations Are Relatively Rare and Not Consistently Associated with Subsequent Relapse.Daniel W. Sherbenou, Michael W. Deininger, Matthew J. Wong et al.|Blood|2005Cited by 6
Differential SUMO-1 distribution in Parkinson’s Disease patient neurosphere-derived cells in response to proteolytic stressMatthew J. Wong, Dean L. Pountney, Anthony L. Cook et al.|Griffith Research Online (Griffith University, Queensland, Australia)|2012Cited by 0